EUVIMEDEUVIMED entdecken
Crossref

Targeting Circ‐OCAC suppress oral squamous cell carcinoma progression

Bowen Li, Yuxun Ding, Chuying Huo, Siqi Ren, Suling Chen, Haizhang He, Shurui Li, Xiaojuan Wang, Meifeng Cen, Hongyu Yang, Jinsong Li iD

Oral Diseases · 2024

DOI: 10.1111/odi.14687 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oral Diseases, 2024. Verfasst von Bowen Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, MicroRNAs, Mouth Neoplasms, RNA, Circular. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, Department of Health of Guangdong Province Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Circular RNAs (circRNAs), with their multilevel and versatile regulation, have emerged as promising targets for treating complex and heterogeneous malignancies such as oral squamous cell carcinoma (OSCC). It is crucial to explore the function of key circRNAs and elucidate the underlying mechanisms to establish an effective in vivo delivery system to better utilize circRNAs as cancer treatment strategies. Materials and Methods circRNA (circ‐OCAC) was identified as significantly downregulated in tumor samples compared to paracancerous tissues by RNA‐seq analysis of eight pairs of OSCC tissues. Functional experiments of circ‐OCAC were performed both in vitro and in vivo . The interactions between circ‐OCAC and miR‐411‐5p were clarified by RNA pull down and RNA immunoprecipitation (RIP) assays.

Results

We observed that circ‐OCAC inhibits OSCC growth and metastasis by blocking the PI3K/Akt signaling pathway. To translate this observation in vivo, a pH‐responsive nanoparticle (pNP) was developed to target circ‐OCAC. Our results confirmed the advantages of the pNP‐circ‐OCAC system: high tumor enrichment capacity and good biosafety, which resulted in a significantly enhanced antitumor effect.

Conclusions

This study demonstrated that targeting circ‐OCAC serves as a promising potential therapeutic strategy for OSCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Squamous CellMicroRNAsMouth NeoplasmsRNA, CircularAnimalsHumansMiceCell Line, TumorCell ProliferationDisease ProgressionDown-RegulationMice, NudeNanoparticlesPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktSignal TransductionFemale

Stichwörter der Autor:innen

Circ‐OCACoral squamous cell carcinomatargeted delivery

Substanzen

MicroRNAsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRNA, Circular

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial Surgery, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, China.
  • Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen Universi…
  • Department of Oral and Maxillofacial Surgery, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China.
  • Longgang E.N.T. Hospital & Shenzhen Key Laboratory of E.N.T, Institute of E.N.T, Shenzhen, Guangdong, China.
  • Department of Gynecological Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
  • Department of Pathology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, China.

ORCID-Profile: Jinsong Li

Förderung

  • China Postdoctoral Science Foundation
  • Department of Health of Guangdong Province Science Foundation
  • National Natural Science Foundation of China
  • Shenzhen Innovation of Science and Technology Commission
  • Shenzhen Science and Technology Program
  • The Science and Technology Program of Guangzhou

Zitieren

APA

Li, B., Ding, Y., Huo, C., Ren, S., Chen, S., He, H., Li, S., Wang, X., Cen, M., Yang, H., & Li, J. (2024). Targeting Circ‐OCAC suppress oral squamous cell carcinoma progression. Oral Diseases. https://doi.org/10.1111/odi.14687

Vancouver

Li B, Ding Y, Huo C, Ren S, Chen S, He H, et al. Targeting Circ‐OCAC suppress oral squamous cell carcinoma progression. Oral Diseases. 2024. doi:10.1111/odi.14687

BibTeX
@article{Li2024,
  author = {Li, Bowen and Ding, Yuxun and Huo, Chuying and Ren, Siqi and Chen, Suling and He, Haizhang and Li, Shurui and Wang, Xiaojuan and Cen, Meifeng and Yang, Hongyu and Li, Jinsong},
  title = {Targeting Circ‐OCAC suppress oral squamous cell carcinoma progression},
  journal = {Oral Diseases},
  year = {2024},
  doi = {10.1111/odi.14687}
}
Kostenlos starten →